ABC News
‘Science by press release’:
Sudden rise of vaccine developer Moderna rankles some in scientific establishment
May 21, 2020, 3:31 PM EDT
The company has been embraced by a Trump administration desperate for good news in the fight against COVID-19. In April, Moderna received $483 million from the Biomedical Advanced Research and Development Authority (BARDA), the government agency charged with overseeing the rapid production of a vaccine. And last week, one of its board members, Moncef Slaoui, was appointed the nation's new "vaccine czar," leading him to resign from his position at the company and announce plans to divest more than $12 million of equity holdings amid concerns about potential conflicts of interest.
But while the announcement of favorable preliminary results has generated widespread excitement and put the company at the forefront of the race for the most sought-after vaccine in more than a century, some in the typically staid and sober scientific establishment have begun to question the company's decision to publicize preliminary results by press release with no supporting data.
https://www.yahoo.com/gma/science-press-release-sudden-rise-vaccine-developer-moderna-193102158–abc-news-topstories.html